Table 2 Magnitudes of physical and biochemical measures, aggregated by ART status, among PLHIV, in the Gedeo-zone, southern-Ethiopia, 2017–2019
S.No | The IDF parameter | Magnitude(%) by ART status | Total | P-value | ||||
|---|---|---|---|---|---|---|---|---|
ART naïve (n = 211) | ART exposed(n = 422) | |||||||
% | 95% CI | % | 95% CI | % | 95% CI | |||
1 | Raised SBP/DBP>/=130/85 mmHga | 54.0 | 47.4–60.2 | 56.4 | 52.1–61.1 | 55.6 | 51.8–59.6 | 0.57 |
2 | Raised blood pressure (BP) (SBP/DBP or Anti-HTN treatment user) | 57.3 | 1.0–1.11 | 56.6 | 1.0–1.07 | 56.9 | 1.03–1.07 | 0.87 |
3 | Raised BMI >/= 30 kg/M2b | 7.6 | 4.3–10.9 | 10.9 | 8.1–13.7 | 9.8 | 7.6–12.2 | 0.19 |
4 | Raised WC (WC > Women 80 or men > 94 cm) | 37.9 | 31.3–44.1 | 42.2 | 37.7–47.2 | 40.8 | 37.1–44.5 | 0.30 |
5 | Central Obesity (CO) (WC or BMI) | 42.7 | 37.4–49.3 | 49.1 | 44.5–53.3 | 46.9 | 43.3–50.7 | 0.13 |
7 | FPG (FPG > 100 mg/dlc or Anti-DM treatment user) | 55.9 | 49.3–62.5 | 56.4 | 52.1–61.1 | 56.2 | 52.6–60.0 | 0.91 |
8 | Raised TGL_c (TGL_c>/=150 mg/dl or treated for TGL_c) | 25.6 | 19.9–31.3 | 42.9 | 37.9–47.4 | 37.1 | 33.0–40.8 | < 0.001 |
9 | Low HDL_c (Women< 50 mg/dl or Men < 40 mg/dl or treated for TGL_c) | 41.2 | 34.6–47.4 | 30.8 | 26.3–35.5 | 34.3 | 30.6–38.1 | 0.009 |